Skip to main content
SpringerLink
Log in
Book cover

Cancer du sein pp 67–82Cite as

Place de l’IRM en sénologie

  • Conference paper

  • 239 Accesses

Conclusion

En vingt ans, l’IRM a vu ses indications régulièrement s’étendre en pathologie mammaire et son potentiel évolutif fait que ses performances s’améliorent constamment. Si l’outil paraît magnifique, il faut le replacer dans le contexte social et médical : versant économique, cet examen reste cher et encore peu disponible; versant médical, son écueil actuel est qu’il n’a pas démontré une amélioration de la survie des patients qui en ont bénéficié.

Il n’est pas certain que nous ayons un jour la réponse. Cependant, il est clair que cet outil permet de résoudre les problèmes des autres techniques d’imagerie, qu’il aide à la compréhension de la pathologie mammaire et à l’évaluation thérapeutique. Le fait qu’elle soit multiparamétrique, avec un potentiel évolutif puissant, lui assure un avenir et une place grandissante dans la détection, la caractérisation et le suivi sous traitement des cancers du sein.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Tardivon A, El Khoury C, Meunier M et al. (2004) Comment nous faisons une IRM mammaire. Feuillets de radiologie 44(2): 133–8

    Google Scholar 

  2. ACR Bi-Rads-IRM (2003) Première édition française basée sur la première édition américaine. American College of Radiology (ACR). ACR-BI-RADSMagnetic Resonance Imaging. In: ACR Breast imaging reporting and data system, Breast Imaging Atlas. Reston, Va: American College of Radiology

    Google Scholar 

  3. Kuhl C, Bieling HB, Gieseke J et al. (1997) Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast enhancement and cyclical-phase dependency. Radiology 203: 137–44

    PubMed  CAS  Google Scholar 

  4. Orel Greenstein S (2000) MR imaging of the breast. Radiol Clin North Am 38(4): 899–13

    Article  Google Scholar 

  5. Azavedo E, Boné B (1999) Imaging breast with silicone implants. Eur Radiol 9: 349–55

    Article  PubMed  CAS  Google Scholar 

  6. Ikeda DM, Borofsky HB, Herfkens RJ et al. (1999) Silicone breast implant rupture: pitfalls of magnetic resonance imaging and relative efficacies of magnetic resonance, mammography, and ultrasound. Plast Reconstructr Surg 104(7): 2054–62

    Article  CAS  Google Scholar 

  7. Cher DJ, Conwell JA, Mandel JS (2001) MRI for detecting silicone breast implant rupture:meta-analysis and implications. Ann Plast Surg 47(4): 367–80

    Article  PubMed  CAS  Google Scholar 

  8. Morris EA (2002) Breast cancer imaging with MRI. Radiol Clin North Am 2002; 40(3): 443–66

    Article  Google Scholar 

  9. Dao TH, Rahmouni A, Servois V et al. (1994) MR imaging of the breast in the follow-up evaluation of conservative nonoperatively treated breast cancer. Magn Reson Imaging Clin N Am 2: 605–22

    PubMed  CAS  Google Scholar 

  10. Gilles R, Thiollier S, Guinebretière JM et al. (1995) Diagnostic des récidives locales du cancer du sein par imagerie par résonance magnétique. J Gynecol Obstet Biol Reprod 24: 788–93

    CAS  Google Scholar 

  11. Whitehouse GH, Moore NR (1994) MR imaging of the breast after surgery for breast cancer. Magn Reson Imaging Clin N Am 2: 591–603

    PubMed  CAS  Google Scholar 

  12. Morakkabati N, Leutner CC, Schmiedel A et al. (2003) Breast MR imaging during or soon after radiation therapy. Radiology 229(3): 893–901

    PubMed  Google Scholar 

  13. Fischer U, Kopka L, Grabbe E (1999) Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 213: 881–8

    PubMed  CAS  Google Scholar 

  14. Esserman L, Hylton N, Yassa L et al. (1999) Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 17(1): 110

    PubMed  CAS  Google Scholar 

  15. Tillman BGF, Orel SG, Schnall MD et al. (2002) Effect of breast magnetic resonance imaging with early-stage breast carcinoma. J Clin Oncol 20(16): 3413–23

    Article  PubMed  Google Scholar 

  16. Sardanelli F, Giuseppetti GM, Panizza P et al. (2004) (Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts unsing the whole-breast pathologic examination as a gold standard. Am J Roentgenol 183: 1149–57

    Google Scholar 

  17. Woo IJ, Orel SG, Schnall MD et al. (2000) MR imaging of the controlateral breast in patients with newly diagnosed breast cancer (abstr). Radiology 217(P): 526

    Google Scholar 

  18. Hlawatsch A, Teikfe A, Schmidt M et al. (2002) Preoperative assessment of breast cancer: sonography versus MR imaging. Am J Roentgenol 179: 1493–1501

    Google Scholar 

  19. Heywang-Köbrunner SH, Heinig A, Schamloeffel U et al. (1999) MR-guided percutaneous and incisional biopsy of breast lesions. Eur Radiol 9(8): 1656–65

    Article  PubMed  Google Scholar 

  20. Heywang-Köbrunner SH, Heinig A, Pickuth D et al. (2000) Interventional MRI of the breast: lesion localisation and biopsy. Eur Radiol 10(1): 36–45

    Article  PubMed  Google Scholar 

  21. Weinstein SP, Greenstein Orel S, Heller R et al. (2001) MR imaging of the breast in patients with invasive lobular carcinoma. Am J Roentgenol 176: 399–406

    CAS  Google Scholar 

  22. Orel SG, Reynolds C, Schnall MD et al. (1997) Breast carcinoma: MR imaging before re-excional biopsy. Radiology 205: 429–36

    PubMed  CAS  Google Scholar 

  23. Soderstrom CE, Harms SE, Farrel RS Jr et al. (1997) Detection with MR imaging of residual tumor in the breast soon after surgery. Am J Roentgenol 168: 485–8

    CAS  Google Scholar 

  24. Frei KA, Kinkel K, Bonel HM et al. (2000) MR imaging of the breast in patients with positive margins after lumpectomy: influence of the time interval between lumpectomy and MR imaging. Am J Roentgenol 175: 1577–84

    CAS  Google Scholar 

  25. Morris EA, Schwartz LH, Drotman MB et al. (2000) Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology 214: 67–72

    PubMed  CAS  Google Scholar 

  26. van der Hage JA, van de Velde CJH, Julien JP et al. (2001) Preoperative chemotherapy in primary operable breast cancer: results from the european organization for research and treatment of cancer trial 10902. J Clin Oncol 19(22): 4224–37

    PubMed  Google Scholar 

  27. Drew PJ, Kerin MJ, Mahapatra T et al. (2001) Evaluation of response to neoadjuvant chemoradiotherapy for locally adavanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 27(7): 617–20

    Article  PubMed  CAS  Google Scholar 

  28. Nakamura S, Kenjo H, Nishio T et al. (2002) Efficacy of 3D-MR mammography for breast conserving surgery after neoadjuvant chemotherapy. Breast Cancer 9(1): 15–9

    Article  PubMed  Google Scholar 

  29. Balu-Maestro C, Chapellier C, Bleuse A et al. (2002) Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 72(2): 145–52

    Article  PubMed  CAS  Google Scholar 

  30. Partridge SC, Gibbs JE, Lu Y et al. (2002) Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. Am J Roentgenol 179: 1193–9

    Google Scholar 

  31. Rosen EL, Blackwell KL, Baker JA et al. (2003) Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy. Am J Roentgenol 181: 1275–82

    Google Scholar 

  32. Thibault F, Nos C, Meunier M et al. (2004) MRI for surgical planning in patients with breast cancer who undergo preoperative chemotherapy. Am J Roentgenol 183: 1159–68

    Google Scholar 

  33. Tsuboi N, Ogawa TN, Inomata T et al. (1999) Changes in the findings of dynamic MRI by preoperative CA chemotherapy for patients with breast cancer of stage II and III: pathologic correlation. Oncol Rep 6(4): 727–32

    PubMed  CAS  Google Scholar 

  34. Martincich L, Montemurro F, De Rosa G et al. (2004) Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 83: 67–76

    Article  PubMed  Google Scholar 

  35. Rieber A, Brambs HJ, Heilmann V et al. (2002) Breast MRI for monitoring response of primary breast cancer to neo-adjuvant chemotherapy. Eur Radiol 12: 1711–9

    Article  PubMed  CAS  Google Scholar 

  36. El Khoury C, Thibault F, Servois V et al. (2002) Evaluation of tumor response to chemotherapy in breast cancer by a quantification method of the wash out (abst.). Radiology 225(P): 120

    Google Scholar 

  37. Warren RML, Bobrow LG, Earl HM et al. (2004) Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy? Br J Cancer 90: 1349–60

    Article  PubMed  CAS  Google Scholar 

  38. Leach MO (2002) The UK national study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). J Exp Clin Cancer Res 21(3) (Suppl) 107–14

    PubMed  CAS  Google Scholar 

  39. Morris EA, Liberman L, Ballon DJ et al. (2003) MRI of occult breast carcinoma in a high risk population. Am J Roentgenol 181: 619–26

    Google Scholar 

  40. Kuhl CK, Schrading S, Leutner C et al. (2003) Surveillance of “high risk” women with proven or suspected familial (hereditary) breast cancer: first mid-term results of a multi-modality clinical screening trial [abstract]. Proc Am Soc Clin Oncol 22: 362a

    Google Scholar 

  41. Kriege M, Brekelmans CT, Boetes C et al. (2004) Efficacy of MRI and mammography for breast cancer screening in women with a familial or genetic predisposition. N Engl J Med 351(5): 497–500

    Article  Google Scholar 

  42. Warner E, Plewes DB, Hill KA et al. (2004) Surveillance of BRCA1 and BRCA 2 mutation carriers with magnetic resonance imaging, ultrasound, mammography and clinical breast examination. JAMA 292(11): 1368–70

    Article  Google Scholar 

  43. ANAES (1998 Nov) Recommandations pour la pratique clinique. Synthèse des recommandations sur le cancer du sein.

    Google Scholar 

  44. Kvistad KA, Rydland J, Vainio J et al. (2000) Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging. Radiology 216: 545–53

    PubMed  CAS  Google Scholar 

  45. Mc Knight AL, Kugel JL, Rossman PJ et al. (2002) MR elastography of breast cancer: preliminary results. Am J Roentgenol 178: 1411–7

    Google Scholar 

  46. Huang W, Fisher PR, Dulaimy K et al. (2004) Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology 232: 585–91

    PubMed  Google Scholar 

  47. Furman-Haran E, Degani H (2002) Parametric analysis of breast MRI. J Comput Assist Tomogr 26(3): 376–86

    Article  PubMed  Google Scholar 

  48. Daldrup-Link HE, Brasch RC (2003) Macromolecular contrast agents for MR mammography: current status. Eur Radiol 13: 354–65

    PubMed  Google Scholar 

  49. Harisinghani MG, Dixon WT, Saksena MA et al. (2004) MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 24: 867–78

    PubMed  Google Scholar 

  50. Michel SVA, Keller TM, Fröhlich JM et al. (2002) Preoperative Breast Cancer Staging: MR Imaging of the Axilla with Ultrasmall Superparamagnetic Iron Oxide Enhancement Radiology 225: 527–36

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service de radiologie, Institut Curie, 26, rue d’Ulm, 75248, Paris Cedex 05

    A. Tardivon

Authors
  1. A. Tardivon
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag France, Paris

About this paper

Cite this paper

Tardivon, A. (2006). Place de l’IRM en sénologie. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/2-287-31109-2_5

Download citation

  • DOI: https://doi.org/10.1007/2-287-31109-2_5

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-25174-0

  • Online ISBN: 978-2-287-31109-3

Publish with us

Policies and ethics

Search

Navigation